The effect of trimetazidine in the treatment of microvascular angina

Kemp HG, Elliott WC, Gorlin R (1967) The anginal syndrome with normal coronary arteriography. Trans Assoc Am Physicians 80:59–70.

Conti CR (1993) What is syndrome X? Clin Cardiol 16:1–3.

Tweddel AC, Martin W, Hutton I Thallium scans in syndrome X. Br Heart J 68:48–50.

Sarrel PM, Lindsay D, Rosano GM, Poole-Wilson PA (1992) Angina and normal coronary arteries in women. Gynecologic findings. Am J Obstet Gynecol 167:467–471.

Rosano GMC, Collins P, Kaski JC, Lindsay DR, Sarrel PM, Poole-Wilson PA (1995) Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 16:610–614.

Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson (1995) Cardiac syndrome X: Clinical characteristics and left ventricular function. J Am Coll Cardiol 25:807–814.

Eriksson B, Suedenhag J, Martinsson A, Sylven C (1995) Effect of epineprine infusion on chest pain in syndrome X in the absence of signs of myocardial ischemia. Am C Cardiol 75:241–245.

Frobert O, Molgaard H, Botker HE, Bagger JP (1995) Autonomic balance in patients with angina and normal coronary angiogram. Eur Heart J 16:1356–1360.

Rosano MMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats AJS, Kaski JC (1994) Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 73:1174–1179.

Chauhan A, Mullins PA, Petch MC, Schofield PM (1994) is coronary flow reserve in response to papaverine really normal in syndrome X. Circulation 89:1998–2004.

Montorsi P, Fabbiocchi F, Loaldi A, Amoni L, Polese A, DeCesare N, Guazzi MD (1991) Coronary adrenergic hyperactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 68:1698–1703.

Crea F, Maseri A (1991) Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X). J Am Coll Cardiol 18:50–54.

Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, L'Abbate A (1994) Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther 8:221–226.

Dean JD, Jones CJ, Hutchinson SJ, Peters JR, Henderson AH (1991) Hyperinsulinaemia and microvascular angina (syndrome X). Lancet 337:456–457.

Chauhan A, Foote J, Petch MC, Schofield PM (1994) Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 23:364–368.

Godsland IF, Crook D, Stevenson JC, Collins P, Rosano GMC, Lees B, Sidhu M, Poole-Wilson PA (1995) Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. 74:47–52. postmenopausal women with cardiological syndrome X. 74:47–52.

Lange K, Nienaber CA, Volk C, Schneider MRE, Koschyk DH. Rinninger F, Meinertz T (1995) Insulin resistance and hyperlipoproteinemia in microvascular angina: Risk factor or pathogenetic link? Coronary Artery Dis 6:797–804.

Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC (1994) Insulin resistance syndrome as a feature of cardiological syndrome X is non-obese men. Br Heart J 71:41–44.

Vestergaard H, Skett P, Stefensen R, Wroblewbki H, Pedersen O, Kastrup J (1995) Insulin-resistant glucose metabolism in patients with microvascular angina-syndrome X. Metabolism 44:876–882.

Emdin M, Picano E, Lattanzi F, L'Abbate A (1989) Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol 14:1450–1453.

Vrints CJM, Bult H, Hitter E, Herman AG, Snoeck JP (1992) Impaired endothelium-dependent cholinergic coronary vasodilatation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol 19:21–31.

Poole-Wilson PA, Crake T (1989) The enigma of syndrome X. Int J Microcirc Clin Exp 8L423–8L432.

Chauhan A (1995) Syndrome X—angina and normal coronary angiography. Postgrad Med J 71:341–345.

Kaski JC, Elliott PM (1995) Angina pectoris and normal coronary arteriograms. Clinical presentation and hemodynamic characteristics. Am J Cardiol 76:35D-42D.

Montorsi P, Cozzi S, Loaldi A, Fabbiocchi F, DeCesare N, Guazzi MD (1990) Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol 66:302–307.

Kaski JC, Rosano G (1994) Effect of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol 23:652–657.

Yoshio H, Shimizu M, Kita Y, Ino H, Kaku B, Taki J, Takeda R (1995) Effects of short-term aminophylline administration on cardiac functional reserve in patients with syndrome X. J Am Coll Cardiol 25:1547–1551.

Radice M, Giudici V, Albertini A, Mannarini A (1994) Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J 127:531–535.

Lonza GA, Manzoli A, Bio E, Crea F, Maseri A (1994) Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation 90:2695–2700.

Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P (1994) Trimetazidine: A new concept in the treatment of angina—comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 37:279–288.

Seller P, Audoin B, Payen B, Corona P, Duogn TC, Ourback P (1987) Acute effects of trimetazidine evaluated by exercise testing. Eur J Pharmacol 33:205–207.

Dalla-Volta S, Maraglino G, Della-Valentina B, Viena P, Desideri A (1990) Comparison of trimetazidine with nifedipine in effort angina: A double-blind study. Cardiovasc Drug Ther 4:853–860.

Broitter L, Barat JL, Combe C, Broussens B, Bonnet J, Bricaud H (1990) Therapeutic value of a cardioprotective agent in patients with severe ischemic cardiomyopathy. Eur Heart J 11:207–212.

Fabiani JN, Ponzio O, Emerit I, Massonet-Castel S, Paris M, Chevalier P, Jabara V, Carpentier A (1992) Cardio-protective effect of trimetazidine during coronary artery graft surgery. Cardiovasc Surg 33:486–491.

Kober G, Bück T, Sievert H, Vallbracht C (1992) Myocardial protection during percutaneous transluminal coronary angioplasty: Effect of trimetazidine. Eur Heart J 13:1109–1115.

Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T (1994) Small vessel pathology and coronary hemodynamics in patients with micro-vascular angina. Int J Cardiol 43:139–150.

Wiedermann JG, Schwartz A, Apfelbaum M (1995) Anatomic and physiologic heterogeneity in patients with syndrome X. J Am Coll Cardiol 25:1310–1317.

Harpey C, Clauser P, Labrid C, Freyria JL, Poirier JP (1989) Trimetazidine, a cellular anti-ischemic agent. Cardiovasc Drug Rev 6:292–312.

Renaud JF (1988) Internal pH, Na+ and Ca++ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drug Ther 1:677–686.

D'Alche P (1990) Electrocardiographical assessment of trimetazidine anti-ischemic properties. Cardiovasc Drug Ther 4:810–811.